BIOMAT Database Logo BIOMAT Database Logo

Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. 1998

J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
Departament de Microbiologia, Hospital Clinic, Facultat de Medicina, Universitat de Barcelona, Villarroel, Spain.

Campylobacter jejuni is a frequent cause of enteritis and sometimes it requires antimicrobial therapy. We have studied the evolution of resistance to nine antibiotics from 1990 to 1994 and investigated how frequently gyrA mutations are involved in the acquisition of quinolone resistance. The percentage of chloramphenicol-, clindamycin-, tetracycline- and amoxicillin plus clavulanic acid-resistant strains has remained practically unchanged and erythromycin and gentamicin resistance has decreased, whereas the percentage of ampicillin-, nalidixic acid- or ciprofloxacin-resistant strains has almost doubled in the follow-up period, from 56 to 76% for ampicillin- and from 47.5 to 88% for quinolone-resistant strains. This study clearly shows that a mutation in Thr-86 to Ile or Lys is a frequent mechanism associated with the acquisition of a high level of resistance to quinolones in clinical isolates of C. jejuni.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002169 Campylobacter Infections Infections with bacteria of the genus CAMPYLOBACTER. Campylobacter Infection,Campylobacteriosis,Infections, Campylobacter,Campylobacterioses,Infection, Campylobacter
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone

Related Publications

J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae.
January 1999, Journal of medical microbiology,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella.
January 1996, Microbial drug resistance (Larchmont, N.Y.),
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations.
March 1993, Antimicrobial agents and chemotherapy,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
High-level quinolone resistance in clinical isolates of Campylobacter jejuni.
April 1992, The Journal of infectious diseases,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
April 2004, Pathology,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
January 2004, Journal of applied microbiology,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Staphylococcus haemolyticus.
April 1996, Antimicrobial agents and chemotherapy,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.
September 1995, Antimicrobial agents and chemotherapy,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
gyrA gene mutations in quinolone-resistant Shigellae flexneri.
January 2001, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
J Ruiz, and P Goñi, and F Marco, and F Gallardo, and B Mirelis, and T Jimenez De Anta, and J Vila
Genetic diversity and quinolone resistance in Campylobacter jejuni isolates from poultry in Senegal.
May 2006, Applied and environmental microbiology,
Copied contents to your clipboard!